Buprenorphine and Naloxone Sublingual Tablets Recalled for Foreign Substance
Sun Pharmaceutical is recalling buprenorphine and naloxone sublingual tablets (8 mg/2 mg) due to a foreign substance. Affected lots DNC1129A and DNC1740A were distributed nationwide.
- Product
- BUPRENORPHINE AND NALOXONE — BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)
- Category
- Drug
- Distribution
- Distributed nationwide